This Article Full Text Full Text (PDF) All Versions of this Article: 35/10/2282    most recent 01.STR.0000141978.33388.ebv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iniesta, J. A. Articles by Corral, J. Search for Related Content PubMed PubMed Citation Articles by Iniesta, J. A. Articles by Corral, J. Related Collections Platelets Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Genetics of Stroke

(Stroke. 2004;35:2282.)
© 2004 American Heart Association, Inc.

Original Contributions

Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage

From the Hematology and Oncology Service (R.G.-C., V.V., J.C.), Centro Regional de Hemodonación, Universidad de Murcia, Spain; the Neurology Section (J.A.I.), Hospital General Universitario, Murcia, Spain; and the Neurosurgery Service (C.P.), Hospital Virgen de la Arrixaca, Murcia, Spain.

Correspondence to Dr Javier Corral, Centro Regional de Hemodonación, C/Ronda de Garay s/n, Murcia 30003, Spain. E-mail jcc{at}um.es

Background and Purpose— Few genetic modifications have been identified to be associated with subarachnoid hemorrhage (SAH), most of them playing a role in the formation or size of aneurysms.

Methods— We evaluated the role of common and functional polymorphisms affecting the main platelet adhesive glycoproteins (GP) (GPIIIa: HPA-1; GPIa: HPA-5 and C807T; GPIb: HPA-2 and VNTR) in the risk for development of the disease and in the severity of the onset. The study was performed in 103 patients with SAH, 103 matched controls, and 473 subjects from the general population.

Results— The HPA-1b (PlA2) allele significantly protected against SAH (OR, 0.48; 95% CI, 0.24 to 0.96; P=0.037). Interestingly, patients carrying this allele displayed larger aneurysms, but the extension of their hemorrhage and the clinical grade at presentation was significantly lower when compared with patients HPA-1 a/a (11.9±2.8 mm versus 8.8±2.2 mm, P=0.0001. Fisher grade 2: 68.4% versus 20%; P=0.0001; Hunt and Hess score <IV; 84.2% versus 53.8%; P=0.0187, respectively). The protection of the HPA-1b allele seemed to be exacerbated by the simultaneous presence of the HPA-2b allele. Thus, no patient carried this combination, which was present in 7.8% of controls (P=0.007).

Conclusions— We present the first evidence suggesting a protective role for the platelet GPIIIa HPA-1b allele in SAH. The suggested platelet hyper-reactivity determined by this allele could reduce the risk to suffer SAH, specially if the aneurysm is small, attenuate the severity of the hemorrhage, and reduce the clinical grade at presentation. This effect might be amplified by the simultaneous combination with the GPIb HPA-2b allele.

Key Words: aneurysm • genetics • hemostasis • subarachnoid hemorrhage

This article has been cited by other articles:

				L. Navarro-Nunez, M. L. Lozano, J. Rivera, J. Corral, V. Roldan, R. Gonzalez-Conejero, J. A. Iniesta, J. Montaner, V. Vicente, and C. Martinez The association of the {beta}1-tubulin Q43P polymorphism with intracerebral hemorrhage in men Haematologica, April 1, 2007; 92(4): 513 - 518. [Abstract] [Full Text] [PDF]